These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19715522)

  • 21. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
    Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
    Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
    Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver.
    Thamboo Tp; Tan KB; Wang SC; Salto-Tellez M
    Pathology; 2003 Aug; 35(4):351-3. PubMed ID: 12959774
    [No Abstract]   [Full Text] [Related]  

  • 28. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
    Hilgard P; Hamami M; Fouly AE; Scherag A; Müller S; Ertle J; Heusner T; Cicinnati VR; Paul A; Bockisch A; Gerken G; Antoch G
    Hepatology; 2010 Nov; 52(5):1741-9. PubMed ID: 21038413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
    Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
    J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.
    Piana PM; Gonsalves CF; Sato T; Anne PR; McCann JW; Bar Ad V; Eschelman DJ; Parker L; Doyle LA; Brown DB
    J Vasc Interv Radiol; 2011 Oct; 22(10):1373-9. PubMed ID: 21764600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
    Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a case report.
    Rivera L; Giap H; Miller W; Fisher J; Hillebrand DJ; Marsh C; Schaffer RL
    World J Gastroenterol; 2006 Sep; 12(35):5729-32. PubMed ID: 17007031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K; Müller S; Antoch G; Hilgard P
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
    Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P
    Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma.
    Yang CW; Yen HH; Su WW; Chen YY; Soon MS
    South Med J; 2010 Dec; 103(12):1264-8. PubMed ID: 21037524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
    Geschwind JF; Salem R; Carr BI; Soulen MC; Thurston KG; Goin KA; Van Buskirk M; Roberts CA; Goin JE
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S194-205. PubMed ID: 15508085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome.
    Hoffman MA; Rubin JI; Vinceguerra VP; Nowakowski FS; Warner RR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1099-102. PubMed ID: 18589326
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
    Nalesnik MA; Federle M; Buck D; Fontes P; Carr BI
    Hum Pathol; 2009 Jan; 40(1):125-34. PubMed ID: 18799190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.